Cancer immune evasion through loss of MHC class I antigen presentation
K Dhatchinamoorthy, JD Colbert, KL Rock - Frontiers in immunology, 2021 - frontiersin.org
Major histocompatibility class I (MHC I) molecules bind peptides derived from a cell's
expressed genes and then transport and display this antigenic information on the cell …
expressed genes and then transport and display this antigenic information on the cell …
Epigenetic modulation of antitumor immunity for improved cancer immunotherapy
Epigenetic mechanisms play vital roles not only in cancer initiation and progression, but also
in the activation, differentiation and effector function (s) of immune cells. In this review, we …
in the activation, differentiation and effector function (s) of immune cells. In this review, we …
Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy
Epigenetics is dynamic and heritable modifications to the genome that occur independently
of DNA sequence. It requires interactions cohesively with various enzymes and other …
of DNA sequence. It requires interactions cohesively with various enzymes and other …
Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer
Triple negative breast cancer (TNBC) is most aggressive subtype of breast cancers with high
probability of metastasis as well as lack of specific targets and targeted therapeutics. TNBC …
probability of metastasis as well as lack of specific targets and targeted therapeutics. TNBC …
Immune checkpoints in the tumor microenvironment
Interactions between immune checkpoints (ICs) and their ligands negatively regulate T cell
activation pathways involved in physiological immune responses against specific antigens …
activation pathways involved in physiological immune responses against specific antigens …
Circulating tumor cells: from new biological insights to clinical practice
X Gu, S Wei, X Lv - Signal Transduction and Targeted Therapy, 2024 - nature.com
The primary reason for high mortality rates among cancer patients is metastasis, where
tumor cells migrate through the bloodstream from the original site to other parts of the body …
tumor cells migrate through the bloodstream from the original site to other parts of the body …
The TIM3/Gal9 signaling pathway: An emerging target for cancer immunotherapy
Immune checkpoint blockade has shown unprecedented and durable clinical response in a
wide range of cancers. T cell immunoglobulin and mucin domain 3 (TIM3) is an inhibitory …
wide range of cancers. T cell immunoglobulin and mucin domain 3 (TIM3) is an inhibitory …
Histone modifications in drug-resistant cancers: From a cancer stem cell and immune evasion perspective
ML **, KW Jeong - Experimental & Molecular Medicine, 2023 - nature.com
The development and immune evasion of cancer stem cells (CSCs) limit the efficacy of
currently available anticancer therapies. Recent studies have shown that epigenetic …
currently available anticancer therapies. Recent studies have shown that epigenetic …
Combinatorial epigenetics impact of polyphenols and phytochemicals in cancer prevention and therapy
I Arora, M Sharma, TO Tollefsbol - International journal of molecular …, 2019 - mdpi.com
Polyphenols are potent micronutrients that can be found in large quantities in various food
sources and spices. These compounds, also known as phenolics due to their phenolic …
sources and spices. These compounds, also known as phenolics due to their phenolic …
[HTML][HTML] Epigenetic strategies synergize with PD-L1/PD-1 targeted cancer immunotherapies to enhance antitumor responses
X Chen, X Pan, W Zhang, H Guo, S Cheng, Q He… - … Pharmaceutica Sinica B, 2020 - Elsevier
Immunotherapy strategies targeting the programmed cell death ligand 1 (PD-
L1)/programmed cell death 1 (PD-1) pathway in clinical treatments have achieved …
L1)/programmed cell death 1 (PD-1) pathway in clinical treatments have achieved …